BREAKING NEWS
UK drug regulator approves Alzheimer's drug but government likely won't pay for it
Read full article: UK drug regulator approves Alzheimer's drug but government likely won't pay for itBritain’s drug regulator has authorized the Alzheimer’s drug Leqembi, saying that it’s the first medicine to show some impact in slowing progression of the neurodegenerative disease.
It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?
Read full article: It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?The first drug shown to slow Alzheimer’s hit the U.S. market over a year ago, but sales have lagged and diagnosis and treatment remain complicated.
FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer's drug
Read full article: FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer's drugFederal regulators are putting off a decision on Eli Lilly’s potential Alzheimer’s treatment with an unusual request to have an advisory committee examine the drug.
First FDA approved drug to slow Alzheimer’s
Read full article: First FDA approved drug to slow Alzheimer’sMore than six million Americans are living with Alzheimer’s disease – it slowly steals your memories and takes away your mind. There is no cure, yet, but now, a newly FDA-approved drug is helping to slow its progression before it’s too late.
Second Alzheimer's drug in pipeline can slow the disease by a few months but with safety risk
Read full article: Second Alzheimer's drug in pipeline can slow the disease by a few months but with safety riskNew research shows another experimental Alzheimer's drug can modestly slow patients' inevitable worsening.
Alzheimer’s drug Leqembi has full FDA approval now and that means Medicare will pay for it
Read full article: Alzheimer’s drug Leqembi has full FDA approval now and that means Medicare will pay for itU.S. officials have granted full approval to a closely watched Alzheimer’s drug for patients with early stages of the disease.
FDA to make a decision on whether to approve first Alzheimer’s drug
Read full article: FDA to make a decision on whether to approve first Alzheimer’s drugThe FDA is set to decide whether it will fully approve the first Alzheimer’s drug to show it could slow the disease’s progression in certain patients. But the decision could also have other implications, including who would get access to it.
